Effectiveness of CASE ultra expert system in evaluating adverse effects of drugs

Molecular Informatics

Volumn 32, Issue 1, 2013, Pages 87-97

  Saiakhov, Roustem ^a   Chakravarti, Suman ^a   Klopman, Gilles ^a,b  

^a MULTICASE Inc   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Adverse effects; CASE Ultra; Expert systems; in silico; QSAR; Risk assessment

Indexed keywords

COMPUTATIONAL CHEMISTRY; EXPERT SYSTEMS; FORECASTING; MOLECULAR GRAPHICS; STATISTICAL TESTS; TOXICITY;

ADVERSE EFFECT; CARDIOTOXICITY; CASE ULTRA; IN-SILICO; LIVER TOXICITY; QSAR; REPRODUCTIVE TOXICITIES; RISKS ASSESSMENTS; SENSITIVITY AND SPECIFICITY; TRAINING SETS;

RISK ASSESSMENT;

ALPIDEM; AMPHETAMINE; BUFORMIN; DOPAMINE; EPHEDRINE; EPININE; LUMIRACOXIB; METHAMPHETAMINE; METHAQUALONE; RIMONABANT; TEGASEROD; TERODILINE; XIMELAGATRAN; ZIMELDINE;

ADVERSE DRUG REACTION; ADVERSE OUTCOME; ARTICLE; BRADYCARDIA; CARCINOGENICITY; CARDIOTOXICITY; CONSENSUS DEVELOPMENT; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; EXPERT SYSTEM; GENETIC ASSOCIATION; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT; URINARY URGENCY;

EID: 84873030500     PISSN: 18681743     EISSN: 18681751     Source Type: Journal    
DOI: 10.1002/minf.201200081     Document Type: Article

References (46)

1. REACH, http://ec.europa.eu/environment/chemicals/reach/reach-intro.htm, accessed July 26, 2012.
2. A. M. Richard, C. R. Williams, Mutat. Res. 2002, 499, 27-52.
3. DSSTox, http://www.epa.gov/ncct/dsstox/, accessed July 26, 2012.
4. ChemIDplus Advanced, http://chem.sis.nlm.nih.gov/chemidplus/, accessed July 26, 2012.
5. N. L. Kruhlak, R. D. Benz, H. Zhou, T. J. Colatsky, Clin. Pharmacol. Ther. 2012, 91, 529-534.
6. N. Greene, Adv. Drug Delivery Rev. 2002, 54, 417-431.
7. B. Mahadevan, R. D. Snyder, M. D. Waters, R. DanielBenz, R. A. Kemper, R. R. Tice, A. M. Richard, Environ. Mol. Mutagen. 2011, 52, 339-354.
8. R. D. Saiakhov, G. Klopman, J. Chem. Inf. Model. 2010, 50, 1521-1521.
9. S. G. Grant, Y. P. Zhang, G. Klopman, H. S. Rosenkranz, Mutat. Res. 2000, 465, 201-229.
10. E. J. Matthews, N. L. Kruhlak, R. Daniel Benz, J. F. Contrera, Regul. Toxicol. Pharmacol. 2007, 47, 115-135.
11. E. J. Matthews, N. L. Kruhlak, R. Daniel Benz, J. Ivanov, G. Klopman, J. F. Contrera, Regul. Toxicol. Pharmacol. 2007, 47, 136-155.
12. C. A. Marchant, L. Fisk, R. R. Note, M. L. Patel, D. Suárez, Chem. Biodiversity 2009, 6, 2107-2114.
13. J. C. Dearden, J. Comput.-Aided Mol. Des. 2003, 17, 119-127.
14. J. C. Dearden, M. D. Barratt, R. Benigni, D. W. Bristol, R. D. Combes, M. T. D. Cronin, P. N. Judson, M. P. Payne, A. M. Richard, M. Tichý, A. P. Worth, J. J. Yourick, ATLA, Altern. Lab. Anim. 1997, 25, 223-252.
15. P. Japertas, R. Didziapetris, A. Petrauskas, Quant. Struct.-Act. Relat. 2002, 21, 23-37.
16. G. Klopman, Quant. Struct.-Act. Relat. 1992, 11, 176-184.
17. DEREK for Windows, Version 10.0.2 Service Pack 3, Lhasa Ltd., Leeds, UK, 2007.
18. K. P. Cross, G. Myatt, C. Yang, M. F. Fligner, J. S. Verducci, P. E. Blower, J. Med. Chem. 2003, 46, 4770-4775.
19. S. K. Chakravarti, R. D. Saiakhov, G. Klopman, J. Chem. Inf. Model. 2012, 52, 2609-2618.
20. G. Klopman, J. Am. Chem. Soc. 1984, 106, 7315-7321.
21. G. Klopman, S. K. Chakravarti, H. Zhu, J. M. Ivanov, R. D. Saiakhov, J. Chem. Inf. Comput. Sci. 2004, 41, 671-678.
22. CaseTox, Version 2.4.0.8, Multicase Inc., Beachwood, OH, 2012.
23. G. Klopman, S. K. Chakravarti, Chemosphere 2003, 51, 445-449.
24. G. Klopman, S. K. Chakravarti, Chemosphere 2003, 51, 461-468.
25. SIDER 2, http://sideeffects.embl.de/, accessed July 26, 2012.
26. M. Kuhn, M. Campillos, I. Letunic, L. J. Jensen, P. Bork, Mol. Syst. Biol. 2010, 6, 1-6.
27. Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women, United States General Accounting Office, Washington, January 19, 2001 http://www.gao.gov/new.items/d01286r.pdf, accessed October 31, 2012.
28. Archive for Recalls, Market Withdrawals & Safety Alerts, US Food and Drug Administration, http://www.fda.gov/Safety/Recalls/ArchiveRecalls/default. htm, accessed October 31, 2012.
29. D. Belk, "Partial List of Medications Recently Withdrawn by the FDA", in The True Cost of Healthcare, http://www.truecostofhealthcare.org/ yahoo-site-admin/assets/ docs/Withdrawn-drugs.15885338.pdf, accessed October 31, 2012.
30. C. E. Shannon, Bell Syst. Tech. J. 1948, 27, 379-423.
31. H. Zhu, A. Sedykh, S. K. Chakravarti, G. Klopman, Curr. Comput.-Aided Drug Des. 2005, 2, 563-569.
32. G. Klopman, H. Zhu, J. Chem. Inf. Comput. Sci. 2001, 41, 439-445.
33. A. K. Ghose, G. M. Crippen, J. Chem. Inf. Comput. Sci. 1987, 27, 21-35.
34. S. Prasanna, R. J. Doerksen, Curr. Med. Chem. 2009, 16, 21-41.
35. J. Gasteiger, M. Marsili, Tetrahedron 1980, 36, 3219-3228.
36. L. H. Hall, B. Mohney, L. B. Kier, J. Chem. Inf. Comput. Sci. 1991, 31, 76-82.
37. R. R. Hocking, Biometrics 1976, 32, 1-49.
38. CDER RCA, http://www.multicase.com/news/cder-rca.htm, accessed July 26, 2012.
39. E. J. Matthews, J. F. Contrera, Regul. Toxicol. Pharmacol. 1998, 28, 242-264.
40. E. J. Matthews, N. L. Kruhlak, J. L. Weaver, R. Daniel Benz, J. F. Contrera, Curr. Drug Discovery Technol. 2004, 1,: 243-54.
41. E. J. Matthews, N. L. Kruhlak, M. C. Cimino, R. Daniel Benz, J. F. Contrera, Regul. Toxicol. Pharmacol. 2006, 44, 83-96.
42. E. J. Matthews, N. L. Kruhlak, M. C. Cimino, R. Daniel Benz, J. F. Contrera, Regul. Toxicol. Pharmacol. 2006, 44, 97-110.
43. A. Berson, V. Descatoire, A. Sutton, D. Fau, B. Maulny, N. Vadrot, G. Feldmann, B. Berthon, T. Tordjmann, D. Pessayre, J. Pharmacol. Exp. Ther. 2001, 299, 793-800.
44. K. Hartigan-Go, D. N. Bateman, A. K. Daly, S. H. Thomas, Clin. Pharmacol. Ther. 1996, 60, 89-98.
45. S. Frascarelli, S. Ghelardoni, G. Chiellini, R. Vargiu, S. Ronca-Testoni, T. S. Scanlan, D. K. Grandy, R. Zucchi, Eur. J. Pharmacol. 2008, 587, 231-236.
46. N. Toda, Y. Matsuda, K. Shimamoto, Int. J. Neuropharmacol. 1969, 451-461.